Nano PharmaSolutions

We make good drugs great by improving bioavailability of drugs through NanoTransformer technology.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location San Diego, CA, USA
  • Currency USD
  • Founded June 2019
  • Employees 5
  • Incorporation Type C-corp
  • Website nanopharmasolutions.com

Company Summary

NPS developed the nanodrug delivery platform that uses no lipids or polymers. This physical nanoplatform uses high vacuum to generate drug nanoparticles by physical vapor deposition (PVD). Using this clean nanotechnology, we are developing pipeline of neuro treatments for direct delivery to brain. The FDA green lighted GMP manufacturing facility opening in 2Q 2024. Ph 1 clinical trial of NT-301 for Parkinson’s Disease is planned for late 2024.

Team

  • Kay Olmstead
    CEO

    Prior to founding Nano PharmaSolutions, Dr. Olmstead served numerous small to medium pharmaceutical companies in worldwide as a CMC subject matter expert, especially in poorly soluble drug development. During past 20 years, Dr. Olmstead played a lead role in the development and the FDA approval of five commercial drugs for San Diego based companies.

Advisors

  • Timothy Day
    Unconfirmed
    MiRa Huyghe
    Unconfirmed
    Debra Gessner
    Unconfirmed
  • William Panenka
    Unconfirmed
    Michael Niesman
    Unconfirmed
    Ingrid Reynolds Niesman
    Unconfirmed

Previous Investors

  • Seedfolio. https://www.seedfolio.vc/
    Unconfirmed
    Ulu Ventures https://uluventures.com/
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free